Review



c4.4a-ab bay 1112623 antibody  (BioInvent)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioInvent c4.4a-ab bay 1112623 antibody
    C4.4a Ab Bay 1112623 Antibody, supplied by BioInvent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c4%2E4a-ab+bay+1112623+antibody/c4+4a+ab+bay+1112623+antibody/10__1158_slash_1535___7163__mct___16___0474-58-1-15
    Average 90 stars, based on 1 article reviews
    c4.4a-ab bay 1112623 antibody - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Generated:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).

    Labeling:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).

    Control:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).

    In Vitro:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).

    Concentration Assay:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).

    Cell Viability Assay:

    Article Title: Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer
    Article Snippet: The C4.4A-Ab (BAY 1112623) was generated by phage display panning using the n-CoDeR® library of BioInvent International AB (24) as described in Supplementary Methods and previously (24-27).



    Similar Products

    c4.4a-ab bay 1112623 antibody  (BioInvent)
    90
    BioInvent c4.4a-ab bay 1112623 antibody
    C4.4a Ab Bay 1112623 Antibody, supplied by BioInvent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c4%2E4a-ab+bay+1112623+antibody/c4+4a+ab+bay+1112623+antibody/10__1158_slash_1535___7163__mct___16___0474-58-1-15
    Average 90 stars, based on 1 article reviews
    c4.4a-ab bay 1112623 antibody - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results